These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 35812383)

  • 21. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
    Sable SB; Posey JE; Scriba TJ
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31666281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
    Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
    PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine.
    Hu Z; Gu L; Li CL; Shu T; Lowrie DB; Fan XY
    Front Immunol; 2018; 9():1796. PubMed ID: 30123219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the development of vaccines for tuberculosis.
    Ahsan MJ
    Ther Adv Vaccines; 2015 May; 3(3):66-75. PubMed ID: 26288734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Childhood tuberculosis: old and new vaccines.
    Hussey G; Hawkridge T; Hanekom W
    Paediatr Respir Rev; 2007 Jun; 8(2):148-54. PubMed ID: 17574159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a new tuberculosis vaccine: is there value in the mucosal approach?
    Diogo GR; Reljic R
    Immunotherapy; 2014; 6(9):1001-13. PubMed ID: 25341121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.
    Xing Z; McFarland CT; Sallenave JM; Izzo A; Wang J; McMurray DN
    PLoS One; 2009 Jun; 4(6):e5856. PubMed ID: 19516906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations of TB vaccine-induced mucosal protection in mice.
    Blazevic A; Eickhoff CS; Stanley J; Buller MR; Schriewer J; Kettelson EM; Hoft DF
    Microbes Infect; 2014 Jan; 16(1):73-9. PubMed ID: 24120457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End-point definition and trial design to advance tuberculosis vaccine development.
    Garcia-Basteiro AL; White RG; Tait D; Schmidt AC; Rangaka MX; Quaife M; Nemes E; Mogg R; Hill PC; Harris RC; Hanekom WA; Frick M; Fiore-Gartland A; Evans T; Dagnew AF; Churchyard G; Cobelens F; Behr MA; Hatherill M
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35675923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK; Khuller GK
    Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies and tuberculosis.
    Jacobs AJ; Mongkolsapaya J; Screaton GR; McShane H; Wilkinson RJ
    Tuberculosis (Edinb); 2016 Dec; 101():102-113. PubMed ID: 27865379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.
    Xing Z; Lichty BD
    Tuberculosis (Edinb); 2006; 86(3-4):211-7. PubMed ID: 16504584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.